Sisram Medical Ltd
SRAMF
$0.535
$0.5350.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.60M | 22.86M | 25.13M | 24.34M | 23.55M |
| Total Depreciation and Amortization | 17.36M | 17.33M | 17.31M | 17.09M | 16.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.02M | -1.83M | 358.00K | 3.36M | 6.36M |
| Change in Net Operating Assets | -9.71M | -9.71M | -9.71M | -8.30M | -6.89M |
| Cash from Operations | 24.23M | 28.66M | 33.08M | 36.49M | 39.89M |
| Capital Expenditure | -3.41M | -3.08M | -2.75M | -4.68M | -6.61M |
| Sale of Property, Plant, and Equipment | -52.00K | -20.50K | 11.00K | 38.00K | 65.00K |
| Cash Acquisitions | -1.76M | -1.76M | -1.76M | -3.36M | -4.96M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.42M | -7.26M | -2.09M | 4.94M | 11.97M |
| Cash from Investing | -17.65M | -12.12M | -6.60M | -3.07M | 458.00K |
| Total Debt Issued | 23.38M | 15.47M | 7.55M | 6.47M | 5.38M |
| Total Debt Repaid | -31.46M | -22.88M | -14.31M | -13.12M | -11.93M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.45M | -9.45M | -9.45M | -9.98M | -10.51M |
| Other Financing Activities | -1.26M | -585.00K | 91.00K | -813.00K | -1.72M |
| Cash from Financing | -18.79M | -17.45M | -16.12M | -17.45M | -18.78M |
| Foreign Exchange rate Adjustments | 2.20M | 696.50K | -806.00K | -2.08M | -3.36M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.01M | -219.00K | 9.57M | 13.89M | 18.21M |